Cargando…
Optical malignancy parameters for monitoring progression of breast cancer neoadjuvant chemotherapy
We introduce and demonstrate use of a novel, diffuse optical tomography (DOT) based breast cancer signature for monitoring progression of neoadjuvant chemotherapy. This signature, called probability of malignancy, is obtained by statistical image analysis of total hemoglobin concentration, blood oxy...
Autores principales: | Busch, David R., Choe, Regine, Rosen, Mark A., Guo, Wensheng, Durduran, Turgut, Feldman, Michael D., Mies, Carolyn, Czerniecki, Brian J., Tchou, Julia, DeMichele, Angela, Schnall, Mitchell D., Yodh, Arjun G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Optical Society of America
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539198/ https://www.ncbi.nlm.nih.gov/pubmed/23304651 http://dx.doi.org/10.1364/BOE.4.000105 |
Ejemplares similares
-
Optically Measured Microvascular Blood Flow Contrast of Malignant Breast Tumors
por: Choe, Regine, et al.
Publicado: (2014) -
Macroscopic optical physiological parameters correlate with microscopic proliferation and vessel area breast cancer signatures
por: Chung, So Hyun, et al.
Publicado: (2015) -
Effects of muscle fiber motion on diffuse correlation spectroscopy blood flow measurements during exercise
por: Shang, Yu, et al.
Publicado: (2010) -
Breast DCE-MRI Kinetic Heterogeneity Tumor Markers: Preliminary Associations With Neoadjuvant Chemotherapy Response()
por: Ashraf, Ahmed, et al.
Publicado: (2015) -
Pretreatment vitamin D level and response to neoadjuvant chemotherapy in women with breast cancer on the I-SPY trial (CALGB 150007/150015/ACRIN6657)
por: Clark, Amy S, et al.
Publicado: (2014)